The Pharma industry is down 4.8% over the last week with Green Thumb Industries the worst performer, down 5.5%. In contrast, iAnthus Capital Holdings has gained 20%. However, the industry is down 56% over the past year. Looking forward, earnings are forecast to grow by 78% annually.
Has the Canadian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 08 Jun 2023 | CA$14.6b | CA$13.3b | -CA$10,398,674,708.00 | 10.3x | -1.4x | 1.1x |
Sat, 06 May 2023 | CA$16.5b | CA$13.3b | -CA$10,297,242,673.00 | 11.1x | -1.6x | 1.2x |
Mon, 03 Apr 2023 | CA$16.3b | CA$13.4b | -CA$10,036,187,625.00 | 8.7x | -1.6x | 1.2x |
Wed, 01 Mar 2023 | CA$19.3b | CA$13.7b | -CA$10,254,161,221.00 | 9.8x | -1.9x | 1.4x |
Fri, 27 Jan 2023 | CA$19.0b | CA$13.5b | -CA$10,087,001,268.00 | 14.4x | -1.9x | 1.4x |
Sun, 25 Dec 2022 | CA$20.0b | CA$13.6b | -CA$10,151,710,113.00 | 12.4x | -2x | 1.5x |
Tue, 22 Nov 2022 | CA$29.1b | CA$13.5b | -CA$10,230,610,337.00 | 10.4x | -2.8x | 2.2x |
Thu, 20 Oct 2022 | CA$27.7b | CA$13.5b | -CA$9,430,518,444.00 | 11.4x | -2.9x | 2.1x |
Sat, 17 Sep 2022 | CA$28.4b | CA$13.1b | -CA$8,843,772,737.00 | 13.8x | -3.2x | 2.2x |
Mon, 15 Aug 2022 | CA$29.3b | CA$12.5b | -CA$8,212,978,013.00 | 13.2x | -3.6x | 2.3x |
Wed, 13 Jul 2022 | CA$26.0b | CA$12.2b | -CA$5,775,145,638.00 | 10.4x | -4.5x | 2.1x |
Fri, 10 Jun 2022 | CA$30.4b | CA$12.2b | -CA$5,480,470,272.00 | 9.9x | -5.5x | 2.5x |
Sun, 08 May 2022 | CA$34.6b | CA$12.0b | -CA$4,925,777,728.00 | 11.6x | -7x | 2.9x |
Tue, 05 Apr 2022 | CA$44.6b | CA$11.6b | -CA$4,640,383,890.00 | 13.3x | -9.6x | 3.8x |
Thu, 03 Mar 2022 | CA$42.5b | CA$10.6b | -CA$4,454,287,976.00 | 13.5x | -9.5x | 4x |
Sat, 29 Jan 2022 | CA$44.4b | CA$10.9b | -CA$4,933,422,632.00 | 11.6x | -9x | 4.1x |
Mon, 27 Dec 2021 | CA$54.9b | CA$10.9b | -CA$4,964,997,894.00 | 13.5x | -11.1x | 5x |
Wed, 24 Nov 2021 | CA$65.1b | CA$10.8b | -CA$4,877,103,503.00 | 19.6x | -13.3x | 6x |
Fri, 22 Oct 2021 | CA$63.7b | CA$10.1b | -CA$4,883,044,951.00 | 19.2x | -13x | 6.3x |
Sun, 19 Sep 2021 | CA$66.8b | CA$10.4b | -CA$6,658,476,418.00 | 21.4x | -10x | 6.4x |
Tue, 17 Aug 2021 | CA$69.0b | CA$10.2b | -CA$6,616,236,433.27 | 22.3x | -10.4x | 6.8x |
Tue, 01 Jun 2021 | CA$81.6b | CA$8.9b | -CA$7,509,828,145.21 | 24.4x | -10.9x | 9.2x |
Fri, 05 Mar 2021 | CA$92.2b | CA$7.6b | -CA$8,166,561,132.27 | 44.4x | -11.3x | 12.2x |
Mon, 07 Dec 2020 | CA$59.6b | CA$6.6b | -CA$10,071,038,851.76 | 26.4x | -5.9x | 9.1x |
Thu, 10 Sep 2020 | CA$41.1b | CA$5.6b | -CA$8,989,610,861.79 | 23.1x | -4.6x | 7.4x |
-3.8x
How does Canadian Pharma compare with similar industries?
CA Market | 2.01% | |
Healthcare | 0.52% | |
Pharma | -1.14% | |
Pharma | -1.14% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CURA Curaleaf Holdings | CA$4.05 | 4.7% +CA$129.4m | -46.3% | PS1.6x | |
IAN iAnthus Capital Holdings | CA$0.03 | 20.0% +CA$32.2m | -66.7% | PS0.9x | |
GSD Devonian Health Group | CA$0.28 | 52.8% +CA$15.2m | -54.2% | PS18x | |
GUD Knight Therapeutics | CA$4.93 | 2.7% +CA$14.2m | -7.0% | PS1.7x | |
OGI Organigram Holdings | CA$0.55 | 7.8% +CA$12.9m | -61.3% | PS1.1x |